Vertex Pharmaceuticals Incorporated VRTX Price Target Raised by RBC Amid Positive Regulatory Milestones and Biotech Sector Tailwinds American Tower Corporation AMT Outperforms Broad Market Selloff But Faces Structural Headwinds Ahead of Q1 2026 Earnings Release BRID Bridgford posts 461 percent Q4 2001 EPS miss shares remain unchanged in todays trading BTZ BlackRock outlines new strategic shifts to optimize credit allocation for sustained income growth CINF Cincy Fin posts 143 percent Q4 2025 EPS beat yet shares slide 22 percent in todays trading session